PainChek – for the pain you cannot C?
Health & Biotech
PainChek is the official new brand for ePAT’s pain detection app.
(“For the pain you cannot C” is not the official slogan — but Stockhead thinks it should be.)
ePAT Technologies (ASX:EPT) will roll out its electronic Pain Assessment Tool app under the new moniker this month at a Melbourne Alzheimer’s conference.
Director Philip Daffas was confident the new name would be a winner.
“Establishing a strong global brand was a key strategic objective to support the market entry as we continue negotiations with potential customers,” he told Stockhead.
“The PainChek branding is best in class and is more than a logo, it makes it stand out in the crowd.”
He said, the decision to drop the ‘c’ was to make it a global brand and allow for easier registration.
The rebrand did little to boost ePAT’s share price on Tuesday however. EPT shares were flat at 4.5c in Tuesday lunchtime trade.
ePAT raised $3.75 million in September to fast-track commercialisation and hoped to make the app available in Australia by the end of the year.
“ePAT is uniquely positioned as a world first regulatory cleared pain assessment App, now recognised by the dementia healthcare professionals,” Mr Daffas said.
“Moreover, following a successful capital raising, we now have market credibility and funding in place to build a sustainable business model and revenue stream in Australia and into international markets over the next year.”
ePAT has been contacted for comment.